Seaport Res Ptn Weighs in on Aspen Aerogels, Inc.’s Q1 2025 Earnings (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN) – Seaport Res Ptn cut their Q1 2025 earnings per share estimates for Aspen Aerogels in a report issued on Thursday, October 10th. Seaport Res Ptn analyst T. Curran now forecasts that the construction company will post earnings of $0.04 per share for the quarter, down from their prior forecast of $0.11. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.21 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.10 EPS, Q3 2025 earnings at $0.14 EPS and Q4 2025 earnings at $0.14 EPS.

A number of other equities research analysts also recently issued reports on the stock. Roth Mkm reiterated a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a research report on Wednesday, August 21st. HC Wainwright boosted their target price on Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. B. Riley upgraded Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Barclays began coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective on the stock. Finally, Benchmark restated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Stock Down 1.4 %

ASPN stock opened at $22.43 on Monday. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The company’s 50-day moving average price is $25.84 and its 200 day moving average price is $24.33. Aspen Aerogels has a 52 week low of $6.62 and a 52 week high of $33.15. The company has a market cap of $1.71 billion, a P/E ratio of -50.98 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business’s revenue was up 144.4% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.22) EPS.

Hedge Funds Weigh In On Aspen Aerogels

A number of large investors have recently modified their holdings of ASPN. Point72 Hong Kong Ltd purchased a new position in shares of Aspen Aerogels in the 2nd quarter valued at $84,000. nVerses Capital LLC purchased a new position in Aspen Aerogels in the second quarter valued at about $95,000. Quent Capital LLC purchased a new position in Aspen Aerogels in the third quarter valued at about $118,000. Banque Cantonale Vaudoise lifted its stake in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares in the last quarter. Finally, Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels in the second quarter worth about $121,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.